Skip to main content
. 2021 May 19;321(2):L429–L439. doi: 10.1152/ajplung.00018.2021

Table 2.

Potential therapies targeting CFH-mediated endothelial injury

Therapy Method of Action References
Haptoglobin Endogenous scavenger of hemoglobin (17, 21, 27, 66, 80, 82, 8486, 88, 90)
Hemopexin Endogenous scavenger of heme (22, 80, 82, 84, 89, 90)
Plasma proteins (e.g. albumin) Binds hemoglobin/heme (69, 93)
Acetaminophen Hemoprotein reductant NCT04291508 (21, 25, 91, 92)
Ascorbate Antioxidant (34, 89)
NO donors [nitrite, nitrate, spermine NONOate (SPNO), S-nitrosoglutathione (GSNO)] Delivers NO (increases bioavailability in hypoxic areas and reduces hemolysis) (24, 94, 95)
Febuxostat Xanthine oxidase inhibitor (96)